ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $123 | +68.5% | 3,490 | +119.5% | 0.00% | – |
Q2 2023 | $73 | -36.5% | 1,590 | -45.4% | 0.00% | – |
Q1 2023 | $115 | -2.5% | 2,910 | +12.9% | 0.00% | – |
Q4 2022 | $118 | -99.9% | 2,578 | +12.1% | 0.00% | – |
Q3 2022 | $95,000 | +75.9% | 2,299 | +146.4% | 0.00% | – |
Q2 2022 | $54,000 | -15.6% | 933 | +4.1% | 0.00% | – |
Q1 2022 | $64,000 | +18.5% | 896 | +36.6% | 0.00% | – |
Q4 2021 | $54,000 | +12.5% | 656 | +21.7% | 0.00% | – |
Q3 2021 | $48,000 | -66.9% | 539 | -65.0% | 0.00% | – |
Q2 2021 | $145,000 | +72.6% | 1,539 | +107.1% | 0.00% | – |
Q1 2021 | $84,000 | -17.6% | 743 | 0.0% | 0.00% | – |
Q4 2020 | $102,000 | +72.9% | 743 | +2.2% | 0.00% | – |
Q3 2020 | $59,000 | -29.8% | 727 | -32.7% | 0.00% | – |
Q2 2020 | $84,000 | +3.7% | 1,081 | -41.1% | 0.00% | – |
Q1 2020 | $81,000 | +350.0% | 1,835 | +322.8% | 0.00% | – |
Q4 2019 | $18,000 | +80.0% | 434 | +70.2% | 0.00% | – |
Q3 2019 | $10,000 | -99.4% | 255 | -98.9% | 0.00% | -100.0% |
Q1 2017 | $1,641,000 | -5.7% | 24,225 | -2.1% | 0.00% | -25.0% |
Q4 2016 | $1,740,000 | -0.9% | 24,750 | 0.0% | 0.00% | +33.3% |
Q3 2016 | $1,755,000 | +45.0% | 24,750 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,210,000 | -22.7% | 24,750 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,566,000 | -45.4% | 24,750 | -3.3% | 0.00% | -57.1% |
Q4 2015 | $2,870,000 | +7.8% | 25,590 | -7.5% | 0.01% | +16.7% |
Q3 2015 | $2,662,000 | – | 27,650 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |